Ngenla®▼ (Somatrogon Injection) the once-weekly growth hormone (GH) for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.¹

Genotropin is a growth hormone therapy indicated for the treatment of growth disturbance in children due to insufficient secretion of growth hormone (growth hormone deficiency, GHD) and growth disturbance associated with Turner Syndrome or chronic renal insufficiency (CRI) or growth disturbance in short children born small for gestational age (SGA) with a birth weight and/or length below –2SD, who failed to show catch-up growth by 4 years of age or later.²

Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-1 concentrations or was not tolerated.³